Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) FCF Margin (2020 - 2025)

KORU Medical Systems has reported FCF Margin over the past 11 years, most recently at 6.31% for Q4 2025.

  • Quarterly results put FCF Margin at 6.31% for Q4 2025, down 482.0% from a year ago — trailing twelve months through Dec 2025 was 1.14% (up 366.0% YoY), and the annual figure for FY2025 was 1.14%, up 366.0%.
  • FCF Margin for Q4 2025 was 6.31% at KORU Medical Systems, up from 0.12% in the prior quarter.
  • Over the last five years, FCF Margin for KRMD hit a ceiling of 15.21% in Q4 2022 and a floor of 66.73% in Q1 2023.
  • Median FCF Margin over the past 5 years was 6.46% (2024), compared with a mean of 15.37%.
  • Biggest five-year swings in FCF Margin: tumbled -5756bps in 2022 and later surged 6088bps in 2024.
  • KORU Medical Systems' FCF Margin stood at 11.73% in 2021, then skyrocketed by 230bps to 15.21% in 2022, then fell by -18bps to 12.53% in 2023, then decreased by -11bps to 11.12% in 2024, then plummeted by -43bps to 6.31% in 2025.
  • The last three reported values for FCF Margin were 6.31% (Q4 2025), 0.12% (Q3 2025), and 4.8% (Q2 2025) per Business Quant data.